For the Inventor, By the Inventor

Enter assignee name

Wiesbaden, Germany

Abbvie Deutschland Gmbh and Co Kg

USPTO Granted Patents = 167

CIPO Patents = 35

EPO Patents = 78

Trademarks = 2

Forward Citations = 374

Loading Chart...

Loading Chart...

276 inventors (with patents filed for the assignee):

Wilfried Hornberger (43 out of 85 patents)

Michael Ochse (34 out of 39 patents)

Wilfried Martin Braje (31 out of 62 patents)

4. Charles W Hutchins (30 out of 69 patents)

5. Udo Lange (29 out of 47 patents)

6. Wilhelm Amberg (29 out of 64 patents)

7. Frauke Pohlki (25 out of 29 patents)

8. Andreas Kling (24 out of 73 patents)

9. Liliane Unger (23 out of 125 patents)

10. Berthold Behl (22 out of 40 patents)

11. Karla Drescher (20 out of 52 patents)

12. Katja Jantos (20 out of 23 patents)

13. Sean Colm Turner (20 out of 49 patents)

14. Hervé Geneste (19 out of 33 patents)

15. Helmut Mack (17 out of 44 patents)

Core Competencies:

Anti-Hemojuvelin Antibodies

Pharmaceutical Formulations

Iron-Related Disorders

S1P Modulators

Monoclonal Antibodies

Phosphodiesterase Inhibitors

Glycogen Synthase Kinase-3 Inhibitors

Amyloid-Beta Binding Proteins

Oxindole Derivatives

Dosing Regimens

Solid Dispersions

Vasopressin-Related Diseases

167 patents: Sort by Forward Citations

1. 12365729 - Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis (2025-07-22),

2. 12251365 - Pharmaceutical formulations for subcutaneous administration (2025-03-18),

3. 12098192 - Composition and method for the diagnosis and treatment of iron-related disorders (2024-09-24),

4. 12098189 - Composition and method for the diagnosis and treatment of iron-related disorders (2024-09-24),

5. 11427598 - Spiro-cyclic amine derivatives as S1P modulators (2022-08-30),

6. 11369599 - Melt-extruded solid dispersions containing an apoptosis-inducing agent (2022-06-28),

7. 11312668 - Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose (2022-04-26),

8. 11285159 - Dosing regimens for use in treating myelofibrosis and MPN-related disorders with navitoclax (2022-03-29),

9. 10836688 - Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose (2020-11-17),

10. 10822403 - Composition and method for the diagnosis and treatment of iron-related disorders (2020-11-03),

11. 10653625 - Production of dosage forms comprising a solid dispersion of a microcrystalline agent (2020-05-19),

12. 10556914 - Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use (2020-02-11),

13. 10556907 - Fused heterocyclic compounds as S1P modulators (2020-02-11),

14. 10538581 - Anti-Aβ globulomer 4D10 antibodies (2020-01-21),

15. 10464976 - Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof (2019-11-05),

AbbVie Deutschland GmbH & Co. KG is a subsidiary of AbbVie Inc., a global biopharmaceutical company specializing in researching, developing, and manufacturing advanced therapies to address challenging health conditions. With a focus on areas such as immunology, oncology, neuroscience, and virology, AbbVie aims to improve the lives of patients by providing innovative treatment options. The German segment of AbbVie contributes to the company's mission by conducting research, clinical trials, and delivering high-quality medicines to patients in Germany.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

167 Patents

#4 in Wiesbaden

#399 in Germany

#4,810 in the World

Wiesbaden, Germany

Abbvie Deutschland Gmbh and Co Kg

Forward Citations = 374

276 inventors:

Wilfried Hornberger (43 out of 85 patents)

Michael Ochse (34 out of 39 patents)

Wilfried Martin Braje (31 out of 62 patents)

4. Charles W Hutchins (30 out of 69 patents)

5. Udo Lange (29 out of 47 patents)

Please report any incorrect information to support@idiyas.com

Loading…